RECRUITING

Pediatric Neuroimaging

Conditions

Neurogimaging Pediatric Neuroimaging Pubertal Adolescents

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Background: Puberty is a normal part of life. Many big changes occur in all parts of the body as a child matures into an adult. Researchers in this study want to find out more about how the brain changes during puberty. Objective: To study changes that occur in the brain before, during, and after puberty. Eligibility: Healthy children aged 9 to 14 years. Design: Participants will have 2 clinic visits. Each visit will last up to 4 hours. In the first visit, participants will be screened: They will have a physical exam with blood tests. They will complete a mental health questionnaire on a computer. They will undergo a mock magnetic resonance imaging (MRI) scan. Participants will be made comfortable as they lie on the table and slide into the big tube. They will learn what it feels and sounds like to lie still inside a real MRI. At the second visit, participants will have more tests: They will have a physical exam with blood tests. This time the doctor will check for their stage of puberty. The doctor will look at and touch their genitals and breasts. They will have a real MRI exam. An x-ray will be taken of their hand and wrist. This will show how their bones are maturing. They will have a DEXA scan. They will lie on a table while a machine uses x-rays to measure the makeup of their bodies, including bone, muscle, and fat. They will have a 3D body scan. They will wear tight clothes and a shower cap. They will stand on a platform while sensors take pictures of their body.

Official Title

A Cross-Sectional Observational Feasibility Pilot Study in Pediatric Neuroimaging: Quantifying White Matter Microstructural Changes in Adolescents With Multidimensional Assessment of Pubertal Stage

Quick Facts

Study Start:2025-04-24

Study Completion:2026-06-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06912724

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:9 Years to 14 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:CHILD

Inclusion Criteria	Exclusion Criteria
* Stated willingness to comply with all study procedures and availability for the duration of the study. * Male or female, 9 to 14 years of age. * In good general health * Ability of parent/guardian to understand and the willingness to sign a written informed consent document. * Ability of participant to participate in the assent process and willingness to sign a written informed assent document.	* Any known brain abnormalities (e.g. tumor, periventricular leukomalacia, microcephaly) or history of medical conditions known to affect cerebral micro or macro-structural integrity (e.g., epilepsy, history of stroke, head injury with a loss of consciousness of one hour or more). * History neurodevelopmental delay or disorder, learning disability, intellectual disability (formerly referred to as mental retardation), autism spectrum disorders, and attention18 deficit/hyperactivity disorder (ADHD)), as evaluated history, physical and by the KSADSCOMP). * History of psychiatric disorder as evaluated by the KSADS-COMP. * History of prematurity (\< 32 weeks gestational age). * History of endocrine abnormalities, including diagnosed disorders of thyroid, growth, and precocious or delayed puberty * History of major medical conditions or chronic medical conditions. Examples include neurological disorders, medical or genetic conditions with associated neurological manifestations, malnutrition, conditions raising risk of micronutrient or macronutrient deficiencies (e.g. inflammatory bowel disease), untreated chronic anemia, cardiovascular disease, significant lung disease (e.g. bronchiectasis), significant liver disease, significant kidney disease, significant autoimmune condition, and chronic infections (e.g. HIV, hepatitis B). * Pregnancy. * Not eligible to have an MRI as per the MRI eligibility form and the safety standards of the NIA 3T MRI center. * Presence of hardware (e.g. orthodontic braces) that may interfere with MRI data quality. * Any other condition which in the investigator s opinion may adversely affect the subject s ability to complete the study or its measures or which may pose significant risk to the subject.

Inclusion Criteria

Exclusion Criteria

* Stated willingness to comply with all study procedures and availability for the duration of the study.
* Male or female, 9 to 14 years of age.
* In good general health
* Ability of parent/guardian to understand and the willingness to sign a written informed consent document.
* Ability of participant to participate in the assent process and willingness to sign a written informed assent document.

* Any known brain abnormalities (e.g. tumor, periventricular leukomalacia, microcephaly) or history of medical conditions known to affect cerebral micro or macro-structural integrity (e.g., epilepsy, history of stroke, head injury with a loss of consciousness of one hour or more).
* History neurodevelopmental delay or disorder, learning disability, intellectual disability (formerly referred to as mental retardation), autism spectrum disorders, and attention18 deficit/hyperactivity disorder (ADHD)), as evaluated history, physical and by the KSADSCOMP).
* History of psychiatric disorder as evaluated by the KSADS-COMP.
* History of prematurity (\< 32 weeks gestational age).
* History of endocrine abnormalities, including diagnosed disorders of thyroid, growth, and precocious or delayed puberty
* History of major medical conditions or chronic medical conditions. Examples include neurological disorders, medical or genetic conditions with associated neurological manifestations, malnutrition, conditions raising risk of micronutrient or macronutrient deficiencies (e.g. inflammatory bowel disease), untreated chronic anemia, cardiovascular disease, significant lung disease (e.g. bronchiectasis), significant liver disease, significant kidney disease, significant autoimmune condition, and chronic infections (e.g. HIV, hepatitis B).
* Pregnancy.
* Not eligible to have an MRI as per the MRI eligibility form and the safety standards of the NIA 3T MRI center.
* Presence of hardware (e.g. orthodontic braces) that may interfere with MRI data quality.
* Any other condition which in the investigator s opinion may adversely affect the subject s ability to complete the study or its measures or which may pose significant risk to the subject.

Contacts and Locations

Study Contact

Tina Gupta, M.D.

CONTACT

(301) 451-0481

tina.gupta@nih.gov

Principal Investigator

Tina Gupta, M.D.

PRINCIPAL_INVESTIGATOR

National Institute on Aging (NIA)

Study Locations (Sites)

National Institute of Aging, Clinical Research Unit

Baltimore, Maryland, 21224

United States

Collaborators and Investigators

Sponsor: National Institute on Aging (NIA)

Tina Gupta, M.D., PRINCIPAL_INVESTIGATOR, National Institute on Aging (NIA)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-24

Study Completion Date2026-06-01

Study Record Updates

Study Start Date2025-04-24

Study Completion Date2026-06-01

Terms related to this study

Keywords Provided by Researchers

Pediatric Neuroimaging Pubertal Adolescents

Additional Relevant MeSH Terms

Neurogimaging